{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:06:29Z","timestamp":1792699589804,"version":"4.5.0"},"reference-count":43,"publisher":"Japanese Society for Magnetic Resonance in Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MRMS","magn reson med sci"],"published-print":{"date-parts":[[2026]]},"DOI":"10.2463\/mrms.mp.2025-0126","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:08:14Z","timestamp":1761862094000},"page":"n\/a","source":"Crossref","is-referenced-by-count":1,"title":["Utility of Locus Coeruleus Signal Intensity on High-resolution T1-weighted MR Imaging with Magnetization Transfer for Differentiating Parkinson\u2019s Disease from Atypical Parkinsonism"],"prefix":"10.2463","volume":"25","author":[{"given":"Yuta","family":"Yoshimatsu","sequence":"first","affiliation":[{"name":"Department of Radiology, University of Occupational and Environmental Health School of Medicine, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6567-6736","authenticated-orcid":false,"given":"Satoru","family":"Ide","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Occupational and Environmental Health School of Medicine, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Occupational and Environmental Health School of Medicine, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Kajio","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Occupational and Environmental Health School of Medicine, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Occupational and Environmental Health School of Medicine, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Futatsuya","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Occupational and Environmental Health School of Medicine, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Occupational and Environmental Health School of Medicine, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyo","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Occupational and Environmental Health School of Medicine, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Adachi","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Occupational and Environmental Health School of Medicine, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatoshi","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Occupational and Environmental Health School of Medicine, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1295","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Fearnley JM, Lees AJ. Ageing and Parkinson\u2019s disease: Substantia nigra regional selectivity. Brain 1991; 114:2283\u20132301.","DOI":"10.1093\/brain\/114.5.2283"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Marino BLB, de Souza LR, Sousa KPA, et al. Parkinson\u2019s disease: A review from pathophysiology to treatment. Mini Rev Med Chem 2020; 20:754\u2013767.","DOI":"10.2174\/1389557519666191104110908"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hattori N, Takeda A, Takeda S, et al. Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson\u2019s disease. J Neural Transm (Vienna) 2019; 126:299\u2013308.","DOI":"10.1007\/s00702-018-1964-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kalia LV, Asis A, Arbour N, et al. Disease-modifying therapies for Parkinson disease: Lessons from multiple sclerosis. Nat Rev Neurol 2024; 20:724\u2013737.","DOI":"10.1038\/s41582-024-01023-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Savoiardo M. Differential diagnosis of Parkinson\u2019s disease and atypical parkinsonian disorders by magnetic resonance imaging. Neurol Sci 2003; 24(Suppl 1):S35\u2013S37.","DOI":"10.1007\/s100720300036"},{"key":"6","unstructured":"6. Osborn AG, Linscott LL, Salzman KL. Osborn\u2019s Brain. Amsterdam:Elsevier, 2023."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Keir G, Roytman M, Mashriqi F, Shahsavarani S, Franceschi AM. Atypical parkinsonian syndromes: Structural, functional, and molecular imaging features. AJNR Am J Neuroradiol 2024; 45:1865\u20131877.","DOI":"10.3174\/ajnr.A8313"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chougar L, Pyatigorskaya N, Degos B, Grabli D, Leh\u00e9ricy S. The role of magnetic resonance imaging for the diagnosis of atypical Parkinsonism. Front Neurol 2020; 11:665.","DOI":"10.3389\/fneur.2020.00665"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Miyata M, Kakeda S, Yoneda T, et al. Signal intensity of cerebral gyri in corticobasal syndrome on phase difference enhanced magnetic resonance images: Comparison of progressive supranuclear palsy and Parkinson\u2019s disease. J Neurol Sci 2020; 419:117210.","DOI":"10.1016\/j.jns.2020.117210"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Miyata M, Kakeda S, Yoneda T, et al. Superior cerebellar peduncle atrophy of progressive supranuclear palsy on phase difference enhanced imaging: A comparison with Parkinson\u2019s disease. Neuroradiology 2023; 65:719\u2013727.","DOI":"10.1007\/s00234-023-03119-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Miyata M, Kakeda S, Toyoshima Y, et al. Potential usefulness of signal intensity of cerebral gyri on quantitative susceptibility mapping for discriminating corticobasal degeneration from progressive supranuclear palsy and Parkinson\u2019s disease. Neuroradiology 2019; 61:1251\u20131259.","DOI":"10.1007\/s00234-019-02253-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ide S, Kakeda S, Yoneda T, et al. Internal structures of the globus pallidus in patients with Parkinson\u2019s disease: Evaluation with phase difference-enhanced imaging. Magn Reson Med Sci 2017; 16:304\u2013310.","DOI":"10.2463\/mrms.mp.2015-0091"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ide S, Kakeda S, Ueda I, et al. Internal structures of the globus pallidus in patients with Parkinson\u2019s disease: evaluation with quantitative susceptibility mapping (QSM). Eur Radiol 2015; 25:710\u2013718.","DOI":"10.1007\/s00330-014-3472-7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Murakami Y, Kakeda S, Watanabe K, et al. Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease. AJNR Am J Neuroradiol 2015; 36:1102\u20131108.","DOI":"10.3174\/ajnr.A4260"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kakeda S, Korogi Y, Yoneda T, et al. Parkinson\u2019s disease: Diagnostic potential of high-resolution phase difference enhanced MR imaging at 3 T. Eur Radiol 2013; 23:1102\u20131111.","DOI":"10.1007\/s00330-012-2680-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ide S, Murakami Y, Futatsuya K, et al. Usefulness of olfactory bulb measurement in 3D-FIESTA in differentiating Parkinson disease from atypical parkinsonism. AJNR Am J Neuroradiol 2024; 45:1141\u20131152.","DOI":"10.3174\/ajnr.A8275"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Huppertz H-J, M\u00f6ller L, S\u00fcdmeyer M, et al. Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification. Mov Disord 2016; 31:1506\u20131517.","DOI":"10.1002\/mds.26715"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sasaki M, Shibata E, Tohyama K, et al. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson\u2019s disease. Neuroreport 2006; 17:1215\u20131218.","DOI":"10.1097\/01.wnr.0000227984.84927.a7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Trujillo P, Aumann MA, Claassen DO. Neuromelanin-sensitive MRI as a promising biomarker of catecholamine function. Brain 2024; 147:337\u2013351.","DOI":"10.1093\/brain\/awad300"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Watanabe T. Neuromelanin? MRI of catecholaminergic neurons. Brain 2024; 147:e24\u2013e26.","DOI":"10.1093\/brain\/awad393"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Trujillo P, Aumann MA, Claassen DO. Reply: Neuromelanin? MRI of catecholaminergic neurons. Brain 2024; 147:e27\u2013e28.","DOI":"10.1093\/brain\/awad394"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ohtsuka C, Sasaki M, Konno K, et al. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson\u2019s disease using neuromelanin-sensitive MR imaging. Neurosci Lett 2013; 541:93\u201398.","DOI":"10.1016\/j.neulet.2013.02.012"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hunt J, Coulson EJ, Rajnarayanan R, Oster H, Videnovic A, Rawashdeh O. Sleep and circadian rhythms in Parkinson\u2019s disease and preclinical models. Mol Neurodegener 2022; 17:2.","DOI":"10.1186\/s13024-021-00504-w"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Chen X, Huddleston DE, Langley J, et al. Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach. Magn Reson Imaging 2014; 32:1301\u20131306.","DOI":"10.1016\/j.mri.2014.07.003"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 2015; 30:1591\u20131601.","DOI":"10.1002\/mds.26424"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Wenning GK, Stankovic I, Vignatelli L, et al. The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord 2022; 37:1131\u20131148.","DOI":"10.1002\/mds.29005"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Armstrong MJ, Litvan I, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013; 80:496\u2013503.","DOI":"10.1212\/WNL.0b013e31827f0fd1"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 1996; 47:1\u20139.","DOI":"10.1212\/WNL.47.1.1"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999; 56:98\u2013102.","DOI":"10.1001\/archneur.56.1.98"},{"key":"30","unstructured":"30. Elble RJ. Diagnostic criteria for essential tremor and differential diagnosis. Neurology 2000; 54(Suppl 4):S2\u2013S6."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Shin H-W, Chung SJ. Drug-induced parkinsonism. J Clin Neurol 2012; 8:15\u201321.","DOI":"10.3988\/jcn.2012.8.1.15"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Wang X, Huang P, Haacke EM, et al. Locus coeruleus and substantia nigra neuromelanin magnetic resonance imaging differentiates Parkinson\u2019s disease and essential tremor. Neuroimage Clin 2023; 38:103420.","DOI":"10.1016\/j.nicl.2023.103420"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ohtsuka C, Sasaki M, Konno K, et al. Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging. Parkinsonism Relat Disord 2014; 20:755\u2013760.","DOI":"10.1016\/j.parkreldis.2014.04.005"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 2016; 15:155\u2013163.","DOI":"10.1016\/j.jcm.2016.02.012"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Kitao S, Matsusue E, Fujii S, et al. Correlation between pathology and neuromelanin MR imaging in Parkinson\u2019s disease and dementia with Lewy bodies. Neuroradiology 2013; 55:947\u2013953.","DOI":"10.1007\/s00234-013-1199-9"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Keren NI, Taheri S, Vazey EM, et al. Histologic validation of locus coeruleus MRI contrast in post-mortem tissue. Neuroimage 2015; 113:235\u2013245.","DOI":"10.1016\/j.neuroimage.2015.03.020"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Cho SJ, Bae YJ, Kim J-M, et al. Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson\u2019s disease and factor analysis for its heterogeneity: A systematic review and meta-analysis. Eur Radiol 2021; 31:1268\u20131280.","DOI":"10.1007\/s00330-020-07240-7"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Wang X, Zhang Y, Zhu C, et al. The diagnostic value of SNpc using NM-MRI in Parkinson\u2019s disease: Meta-analysis. Neurol Sci 2019; 40:2479\u20132489.","DOI":"10.1007\/s10072-019-04014-y"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Trujillo P, Summers PE, Ferrari E, et al. Contrast mechanisms associated with neuromelanin-MRI. Magn Reson Med 2017; 78:1790\u20131800.","DOI":"10.1002\/mrm.26584"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Wolters AF, Heijmans M, Priovoulos N, et al. Neuromelanin related ultra-high field signal intensity of the locus coeruleus differs between Parkinson\u2019s disease and controls. Neuroimage Clin 2023; 39:103479.","DOI":"10.1016\/j.nicl.2023.103479"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Wang J, Li Y, Huang Z, et al. Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in <i>de novo<\/i> Parkinson\u2019s disease and its phenotypes. Eur J Neurol 2018; 25:949\u2013e73.","DOI":"10.1111\/ene.13628"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Nobileau A, Gaurav R, Chougar L, et al. Neuromelanin-sensitive magnetic resonance imaging changes in the locus coeruleus\/subcoeruleus complex in patients with typical and atypical parkinsonism. Mov Disord 2023; 38:479\u2013484.","DOI":"10.1002\/mds.29309"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Matsuura K, Ii Y, Maeda M, et al. Neuromelanin-sensitive magnetic resonance imaging in disease differentiation for parkinsonism or neurodegenerative disease affecting the basal ganglia. Parkinsonism Relat Disord 2021; 87:75\u201381.","DOI":"10.1016\/j.parkreldis.2021.05.002"}],"container-title":["Magnetic Resonance in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/25\/1\/25_mp.2025-0126\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:04:11Z","timestamp":1772251451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/25\/1\/25_mp.2025-0126\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2463\/mrms.mp.2025-0126","relation":{},"ISSN":["1347-3182","1880-2206"],"issn-type":[{"value":"1347-3182","type":"print"},{"value":"1880-2206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"mp.2025-0126"}}